Levetiracetam (Page 10 of 10)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 250 mg (500 Tablets Bottle)

Rx only
NDC 16714-354-02
Levetiracetam
Tablets USP
250 mg
PHARMACIST: PLEASE DISPENSE WITH
MEDICATION GUIDE PROVIDED SEPARATELY.
500 Tablets NorthStar RxTM

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 250 mg (500 Tablets Bottle)
(click image for full-size original)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 500 mg (500 Tablets Bottle)

Rx only
NDC 16714-355-02

Levetiracetam
Tablets USP
500 mg
PHARMACIST: PLEASE DISPENSE WITH
MEDICATION GUIDE PROVIDED SEPARATELY.
500 Tablets NorthStar RxTM

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 500 mg (500 Tablets Bottle)
(click image for full-size original)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 750 mg (500 Tablets Bottle)

Rx only
NDC 16714-356-02

Levetiracetam
Tablets USP
750 mg
PHARMACIST: PLEASE DISPENSE WITH
MEDICATION GUIDE PROVIDED
SEPARATELY.
500 Tablets NORTHSTARTM

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 750 mg (500 Tablets Bottle)
(click image for full-size original)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 750 mg (500 Tablets Bottle)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 1000 mg (60 Tablets Bottle)

Rx only
NDC 16714-357-01
Levetiracetam
Tablets USP
1000 mg
PHARMACIST: PLEASE DISPENSE WITH
MEDICATION GUIDE PROVIDED SEPARATELY.
60 Tablets NORTHSTARTM

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 750 mg (500 Tablets Bottle)
(click image for full-size original)
LEVETIRACETAM levetiracetam tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:16714-354
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVETIRACETAM (LEVETIRACETAM) LEVETIRACETAM 250 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
SILICON DIOXIDE
POVIDONE K30
TALC
MAGNESIUM STEARATE
HYPROMELLOSE 2910 (3 MPA.S)
HYPROMELLOSE 2910 (6 MPA.S)
TITANIUM DIOXIDE
POLYETHYLENE GLYCOL 4000
WATER
FD&C BLUE NO. 2
Product Characteristics
Color BLUE Score 2 pieces
Shape OVAL (Biconvex) Size 15mm
Flavor Imprint Code E;10
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:16714-354-01 120 TABLET, FILM COATED in 1 BOTTLE None
2 NDC:16714-354-02 500 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078993 01/15/2009
LEVETIRACETAM levetiracetam tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:16714-355
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVETIRACETAM (LEVETIRACETAM) LEVETIRACETAM 500 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
SILICON DIOXIDE
POVIDONE K30
TALC
MAGNESIUM STEARATE
HYPROMELLOSE 2910 (3 MPA.S)
HYPROMELLOSE 2910 (6 MPA.S)
TITANIUM DIOXIDE
POLYETHYLENE GLYCOL 4000
WATER
FERRIC OXIDE YELLOW
Product Characteristics
Color YELLOW Score 2 pieces
Shape OVAL (Biconvex) Size 18mm
Flavor Imprint Code E;11
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:16714-355-01 120 TABLET, FILM COATED in 1 BOTTLE None
2 NDC:16714-355-02 500 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078993 01/15/2009
LEVETIRACETAM levetiracetam tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:16714-356
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVETIRACETAM (LEVETIRACETAM) LEVETIRACETAM 750 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
SILICON DIOXIDE
POVIDONE K30
TALC
MAGNESIUM STEARATE
HYPROMELLOSE 2910 (3 MPA.S)
HYPROMELLOSE 2910 (6 MPA.S)
TITANIUM DIOXIDE
POLYETHYLENE GLYCOL 4000
WATER
FD&C YELLOW NO. 6
FD&C BLUE NO. 2
FERRIC OXIDE RED
Product Characteristics
Color ORANGE Score 2 pieces
Shape OVAL (Biconvex) Size 20mm
Flavor Imprint Code E;12
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:16714-356-01 120 TABLET, FILM COATED in 1 BOTTLE None
2 NDC:16714-356-02 500 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078993 01/15/2009
LEVETIRACETAM levetiracetam tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:16714-357
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVETIRACETAM (LEVETIRACETAM) LEVETIRACETAM 1000 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
SILICON DIOXIDE
POVIDONE K30
TALC
MAGNESIUM STEARATE
HYPROMELLOSE 2910 (5 MPA.S)
TITANIUM DIOXIDE
POLYETHYLENE GLYCOL 400
WATER
Product Characteristics
Color WHITE (White to Off-white) Score 2 pieces
Shape OVAL (Modified Oval, Biconvex) Size 22mm
Flavor Imprint Code E;13
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:16714-357-01 60 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078993 01/15/2009
Labeler — NorthStar Rx LLC (830546433)
Registrant — Aurobindo Pharma Limited (650082092)
Establishment
Name Address ID/FEI Operations
Aurobindo Pharma Limited 918917642 ANALYSIS (16714-354), ANALYSIS (16714-355), ANALYSIS (16714-356), ANALYSIS (16714-357), MANUFACTURE (16714-354), MANUFACTURE (16714-355), MANUFACTURE (16714-356), MANUFACTURE (16714-357)

Revised: 02/2020 NorthStar Rx LLC

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.